Concepedia

Lynn M. Georgic

LM

10

Publications

549

Citations

10

H-Index

1994

Active since

Affiliations

Pfizer (United States)(Current)

Lynn M. Georgic is an author at Pfizer (United States) specializing in medicine, pharmacology, and drug discovery.

Top concepts

Publications per year

1994–1999

10

Publications

10

Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.

Thomas A. Pugsley, M. Duff Davis, Hyacinth C. Akunne et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 201 citations

Substituted [(4-Phenylpiperazinyl)- methyl]benzamides:  Selective Dopamine D<sub>4</sub> Agonists

Shelly A. Glase, Hyacinth C. Akunne, Lynn M. Georgic et al. · Journal of Medicinal Chemistry · 1997 · 105 citations · Full text

, , +15

Differential interaction of β1- and β3-adrenergic receptors with Gi in rat adipocytes

Robert G. MacKenzie, Lynn M. Georgic, James G. Granneman · Cellular Signalling · 1994 · 102 citations

, , +12

Aminopyrimidines with High Affinity for Both Serotonin and Dopamine Receptors

David J. Wustrow, Thomas R. Belliotti, Shelly A. Glase et al. · Journal of Medicinal Chemistry · 1998 · 30 citations · Full text

, , +14

A Series of 6- and 7-Piperazinyl- and -Piperidinylmethylbenzoxazinones with Dopamine D4 Antagonist Activity:  Discovery of a Potential Atypical Antipsychotic Agent

Thomas R. Belliotti, David J. Wustrow, Wouter A. Brink et al. · Journal of Medicinal Chemistry · 1999 · 26 citations · Full text

Rows per page

1–5 of 10